Navigation Links
Kanzius Cancer Research Foundation Earns $1 for Each New Facebook Fan
Date:4/14/2011

ERIE, Pa., April 14, 2011 /PRNewswire/ -- In an effort to match last year's $250,000 Pepsi Refresh Everything grant, the Kanzius Cancer Research Foundation (KCRF) launched the "Repeat the Wave" Campaign on April 1 raising over $40,000 and adding more than 4,000 new Facebook fans in thirteen days. Until April 30, KCRF is increasing awareness and raising additional funds for research of the Kanzius Non-Invasive Radiowave Cancer Treatment by asking the public to "like" them on Facebook.

An anonymous donor has agreed to donate one dollar for each new KCRF Facebook fan as well as match fifty cents for each dollar donated to the Foundation. After a Facebook user likes the page, they are then encouraged to "Spread the Wave" by inviting all of their Facebook friends to also "like" the Kanzius Cancer Research Foundation page. The campaign urges KCRF supporters to use a special landing page, www.RepeatTheWave.com, and invite their social networks to spread the wave just like last April, when Internet users and Facebook fans voted KCRF's project as the most "refreshing idea" during the Pepsi Refresh Everything contest. Since the start of this campaign, KCRF has increased support on local, national and global levels.

"A year ago, we embarked on a journey to 'Spread the Wave' and thanks to overwhelming community support, we won the Pepsi contest resulting in a grant of $250,000 to educate new audiences; this has truly transformed our foundation," said Mark A. Neidig, Sr., executive director of Kanzius Foundation. "Today, I am once again humbled by the tremendous support for the 'Repeat the Wave' campaign.  No doubt, everyone has been touched by cancer in some way.  The 'Kanzius Way' of treating cancer non-invasively and without side effects is why we won the grant last year and today, this timely message is still refreshing and worth repeating!"

About the Kanzius Cancer Research Foundation

The Kanzius Cancer Research Foundation is a 501(c) (3) non-profit organization with a mission to create national and global awareness of the potentials of the Kanzius Non-invasive Radiowave Cancer Treatment, and to help accelerate the speed at which this research progresses to human trials. The goal of KCRF is to raise money to support ongoing research grants.  Pancreatic, liver and colorectal cancers in test subjects are undergoing extensive research in Houston and Pittsburgh; additional, ongoing studies are currently focused on breast, leukemic, lung, melanomic and prostate cancers. John Kanzius' sophisticated radio transmission machine is being manufactured in Erie, Pa.  For more information about the Kanzius research, visit www.Kanzius.org.


'/>"/>
SOURCE Kanzius Cancer Research Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... The Rebound mobile app is poised to become a vital ... prescription drug addiction. The app empowers users to develop an ... their dosage in a safe, controlled manner while maximizing well-being. ... 100,000 people to sign up will enjoy 3 months of ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association ... standards of excellence for the field of eating disorders, announces the opening of ... 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. , ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
Breaking Medicine News(10 mins):